首页> 美国政府科技报告 >Mortality and Tumour Recurrence after Irradiation of a Carcinoma of the Cervix with Simultaneous Heparin Therapy
【24h】

Mortality and Tumour Recurrence after Irradiation of a Carcinoma of the Cervix with Simultaneous Heparin Therapy

机译:同时肝素治疗照射子宫颈癌后死亡率和肿瘤复发

获取原文

摘要

A recent study at the gynaecological university hospital of Munich on anticoagulant treatment parallel to the irradiation of female genital cancer has shown that the prognosis will be improved by 10%. The present paper intends to find out whether these results are generally valid. A total of 352 patients was investigated, 200 of them with stage II tumours and 152 with stageIII tumours. 197 of them were given calciparin during the radium treatment, while 155 received no protection. Contrary to the findings of the Munich hospital, radiotherapy alone had a better prognosis in both cases. The two therapy groups were compared with a view to early tumour recurrence. Here, too, the prognosis was better for patients without calciparin protection. All in all, the results were unable to confirm an improved prognosis under the influence of calciparin. In fact, death rates were lower with the conventional treatment. (Atomindex citation 11:555174)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号